In this report, the study analysis was given on a worldwide scale, for instance, present and traditional Extracorporeal Membrane Oxygenation (ECMO) Machinegrowth analysis, competitive analysis, and also the growth prospects of the central regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from sales, revenue and consumption. A quantitative and qualitative analysis of the main players in related regions is introduced, from the perspective of sales, revenue and price.
According to XYZResearch, the global Extracorporeal Membrane Oxygenation (ECMO) Machine market was valued at USD xxx million in 2019, and it is expected to reach a value of USD xxx million by 2026, at a CAGR of xx% over the forecast period 2021-2026. Correspondingly, the forecast analysis of Extracorporeal Membrane Oxygenation (ECMO) Machine industry comprises of Asia, North America, South America, Middle East and Africa, Europe, with the sales and revenue data in each of the sub-segments.
At the upcoming section, this report discusses industrial policy, economic environment, in addition to the fabrication processes and cost structures of the industry. And this report encompasses the fundamental dynamics of the market which include drivers, opportunities, and challenges faced by the industry. Additionally, this report showed a keen market study of the main consumers, raw material manufacturers and distributors, etc.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Extracorporeal Membrane Oxygenation (ECMO) Machine in these regions, from 2014 to 2026 (forecast), covering
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Extracorporeal Membrane Oxygenation (ECMO) Machine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Getinge Group (Sweden)
Medtronic plc (Ireland)
LivaNova PLC (U.K.)
XENIOS AG (Germany)
Terumo Corporation (Japan)
MicroPort Scientific Corporation (China)
NIPRO Corporation (Japan)
OriGen Biomedical, Inc. (U.S.)
ALung Technologies, Inc. (Germany)
EUROSETS S.r.l. (Italy)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Venoarterial (VA)
Venovenous (VV)
Arteriovenous (AV)
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Extracorporeal Membrane Oxygenation (ECMO) Machine for each application, including
Respiratory
Cardiac
Extracorporeal Cardiopulmonary Resuscitation (ECPR)
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Extracorporeal Membrane Oxygenation (ECMO) Machine Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Venoarterial (VA) Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Venovenous (VV) Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.3 Arteriovenous (AV) Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Extracorporeal Membrane Oxygenation (ECMO) Machine Market Assessment by Type
8.1 Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Assessment by Application (Consumption and Market Share)
8.2 North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Assessment by Application (Consumption and Market Share)
8.3 Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Assessment by Application (Consumption and Market Share)
8.4 South America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Getinge Group (Sweden)
9.1.1 Getinge Group (Sweden) Profiles
9.1.2 Getinge Group (Sweden) Product Portfolio
9.1.3 Getinge Group (Sweden) Extracorporeal Membrane Oxygenation (ECMO) Machine Business Performance
9.1.4 Getinge Group (Sweden) Extracorporeal Membrane Oxygenation (ECMO) Machine Business Development and Market Status
9.2 Medtronic plc (Ireland)
9.2.1 Medtronic plc (Ireland) Profiles
9.2.2 Medtronic plc (Ireland) Product Portfolio
9.2.3 Medtronic plc (Ireland) Extracorporeal Membrane Oxygenation (ECMO) Machine Business Performance
9.2.4 Medtronic plc (Ireland) Extracorporeal Membrane Oxygenation (ECMO) Machine Business Development and Market Status
9.3 LivaNova PLC (U.K.)
9.3.1 LivaNova PLC (U.K.) Profiles
9.3.2 LivaNova PLC (U.K.) Product Portfolio
9.3.3 LivaNova PLC (U.K.) Extracorporeal Membrane Oxygenation (ECMO) Machine Business Performance
9.3.4 LivaNova PLC (U.K.) Extracorporeal Membrane Oxygenation (ECMO) Machine Business Development and Market Status
9.4 XENIOS AG (Germany)
9.4.1 XENIOS AG (Germany) Profiles
9.4.2 XENIOS AG (Germany) Product Portfolio
9.4.3 XENIOS AG (Germany) Extracorporeal Membrane Oxygenation (ECMO) Machine Business Performance
9.4.4 XENIOS AG (Germany) Extracorporeal Membrane Oxygenation (ECMO) Machine Business Development and Market Status
9.5 Terumo Corporation (Japan)
9.5.1 Terumo Corporation (Japan) Profiles
9.5.2 Terumo Corporation (Japan) Product Portfolio
9.5.3 Terumo Corporation (Japan) Extracorporeal Membrane Oxygenation (ECMO) Machine Business Performance
9.5.4 Terumo Corporation (Japan) Extracorporeal Membrane Oxygenation (ECMO) Machine Business Development and Market Status
9.6 MicroPort Scientific Corporation (China)
9.6.1 MicroPort Scientific Corporation (China) Profiles
9.6.2 MicroPort Scientific Corporation (China) Product Portfolio
9.6.3 MicroPort Scientific Corporation (China) Extracorporeal Membrane Oxygenation (ECMO) Machine Business Performance
9.6.4 MicroPort Scientific Corporation (China) Extracorporeal Membrane Oxygenation (ECMO) Machine Business Development and Market Status
9.7 NIPRO Corporation (Japan)
9.7.1 NIPRO Corporation (Japan) Profiles
9.7.2 NIPRO Corporation (Japan) Product Portfolio
9.7.3 NIPRO Corporation (Japan) Extracorporeal Membrane Oxygenation (ECMO) Machine Business Performance
9.7.4 NIPRO Corporation (Japan) Extracorporeal Membrane Oxygenation (ECMO) Machine Business Development and Market Status
9.8 OriGen Biomedical, Inc. (U.S.)
9.8.1 OriGen Biomedical, Inc. (U.S.) Profiles
9.8.2 OriGen Biomedical, Inc. (U.S.) Product Portfolio
9.8.3 OriGen Biomedical, Inc. (U.S.) Extracorporeal Membrane Oxygenation (ECMO) Machine Business Performance
9.8.4 OriGen Biomedical, Inc. (U.S.) Extracorporeal Membrane Oxygenation (ECMO) Machine Business Development and Market Status
9.9 ALung Technologies, Inc. (Germany)
9.9.1 ALung Technologies, Inc. (Germany) Profiles
9.9.2 ALung Technologies, Inc. (Germany) Product Portfolio
9.9.3 ALung Technologies, Inc. (Germany) Extracorporeal Membrane Oxygenation (ECMO) Machine Business Performance
9.9.4 ALung Technologies, Inc. (Germany) Extracorporeal Membrane Oxygenation (ECMO) Machine Business Development and Market Status
9.10 EUROSETS S.r.l. (Italy)
9.10.1 EUROSETS S.r.l. (Italy) Profiles
9.10.2 EUROSETS S.r.l. (Italy) Product Portfolio
9.10.3 EUROSETS S.r.l. (Italy) Extracorporeal Membrane Oxygenation (ECMO) Machine Business Performance
9.10.4 EUROSETS S.r.l. (Italy) Extracorporeal Membrane Oxygenation (ECMO) Machine Business Development and Market Status
10 World Extracorporeal Membrane Oxygenation (ECMO) Machine Market Assessment by Players
10.1 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Price (USD/Unit) of Players 2014-2020
10.4 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Extracorporeal Membrane Oxygenation (ECMO) Machine Sales Assessment of Players 2014-2020
11.1.2 North America Extracorporeal Membrane Oxygenation (ECMO) Machine Revenue Assessment of Players 2014-2020
11.1.3 North America Extracorporeal Membrane Oxygenation (ECMO) Machine Price Assessment of Players 2014-2020
11.1.4 North America Extracorporeal Membrane Oxygenation (ECMO) Machine Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Sales Assessment of Players 2014-2020
11.2.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Price Assessment of Players 2014-2020
11.2.4 Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Extracorporeal Membrane Oxygenation (ECMO) Machine Sales Assessment of Players 2014-2020
11.4.2 South America Extracorporeal Membrane Oxygenation (ECMO) Machine Revenue Assessment of Players 2014-2020
11.4.3 South America Extracorporeal Membrane Oxygenation (ECMO) Machine Price Assessment of Players 2014-2020
11.4.4 South America Extracorporeal Membrane Oxygenation (ECMO) Machine Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Extracorporeal Membrane Oxygenation (ECMO) Machine Sales by Countries/Regions 2014-2020
12.2.2 North America Extracorporeal Membrane Oxygenation (ECMO) Machine Revenue by Countries/Regions 2014-2020
12.2.3 North America Extracorporeal Membrane Oxygenation (ECMO) Machine Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Sales by Countries/Regions 2014-2020
12.3.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Revenue by Countries/Regions 2014-2020
12.3.3 Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Extracorporeal Membrane Oxygenation (ECMO) Machine Sales by Countries/Regions 2014-2020
12.4.2 South America Extracorporeal Membrane Oxygenation (ECMO) Machine Revenue by Countries/Regions 2014-2020
12.4.3 South America Extracorporeal Membrane Oxygenation (ECMO) Machine Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Extracorporeal Membrane Oxygenation (ECMO) Machine Sales & Revenue Forecast 2021-2026
14.1 World Extracorporeal Membrane Oxygenation (ECMO) Machine Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Extracorporeal Membrane Oxygenation (ECMO) MachineSales and Market Share by Regions
14.1.2 World Extracorporeal Membrane Oxygenation (ECMO) MachineRevenue and Market Share by Regions
15 Asia Extracorporeal Membrane Oxygenation (ECMO) Machine Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Venoarterial (VA)
15.1.2 Venovenous (VV)
15.1.3 Arteriovenous (AV)
15.2 Consumption Forecast by Application, 2021-2026
16 North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Venoarterial (VA)
16.1.2 Venovenous (VV)
16.1.3 Arteriovenous (AV)
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Venoarterial (VA)
17.1.2 Venovenous (VV)
17.1.3 Arteriovenous (AV)
17.2 Consumption Forecast by Application, 2021-2026
18 South America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Venoarterial (VA)
18.1.2 Venovenous (VV)
18.1.3 Arteriovenous (AV)
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Venoarterial (VA)
19.1.2 Venovenous (VV)
19.1.3 Arteriovenous (AV)
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Price (USD/Unit) Trend 2021-2026
20.2 Global Extracorporeal Membrane Oxygenation (ECMO) Machine Gross Profit Trend 2021-2026
21 Conclusion